Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MKS INC Investor Presentation 2021

Jul 8, 2021

30723_rns_2021-07-08_a3647428-2df0-46e0-99a4-33c6bf884cf9.zip

Investor Presentation

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 8, 2021

MKS Instruments, Inc.

(Exact name of registrant as specified in its charter)

Massachusetts 000-23621 04-2277512
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
2 Tech Drive , Suite 201 , Andover , Massachusetts 01810
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: 978 - 645-5500

Not Applicable

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value MKSI Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On July 8, 2021, MKS Instruments, Inc. (the “Company”) updated its investor presentation relating to its previously announced entry into a definitive agreement (the “Implementation Agreement”) with Atotech Limited (“Atotech”) on July 1, 2021, providing for, subject to the terms and conditions of the Implementation Agreement, the acquisition of Atotech by the Company. The updated investor deck is available on the Investor Relations page of the Company’s website at https://investor.mksinst.com/ and will be used at investor and other meetings. A copy of the updated Investor Presentation is furnished as Exhibit 99.1 and incorporated herein by reference. The Company does not undertake to update this presentation.

The information contained in Item 7.01 of this Current Report and in the accompanying exhibit is being furnished pursuant to Item 7.01 and shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Investor Presentation dated July 1, 2021 (updated as of July 8, 2021)
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MKS Instruments, Inc. — By: /s/ Kathleen F. Burke
Date: July 8, 2021 Name: Kathleen F. Burke
Title: Senior Vice President, General Counsel and Secretary